565 related articles for article (PubMed ID: 27226551)
61. An
Cascella R; Banchelli M; Abolghasem Ghadami S; Ami D; Gagliani MC; Bigi A; Staderini T; Tampellini D; Cortese K; Cecchi C; Natalello A; Adibi H; Matteini P; Chiti F
Ann Med; 2023 Dec; 55(1):72-88. PubMed ID: 36495262
[No Abstract] [Full Text] [Related]
62. The Lysosomal Trafficking Transmembrane Protein 106B Is Linked to Cell Death.
Suzuki H; Matsuoka M
J Biol Chem; 2016 Oct; 291(41):21448-21460. PubMed ID: 27563066
[TBL] [Abstract][Full Text] [Related]
63. Roles of ataxin-2 in pathological cascades mediated by TAR DNA-binding protein 43 (TDP-43) and Fused in Sarcoma (FUS).
Nihei Y; Ito D; Suzuki N
J Biol Chem; 2012 Nov; 287(49):41310-23. PubMed ID: 23048034
[TBL] [Abstract][Full Text] [Related]
64. RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.
Hofmann JW; Seeley WW; Huang EJ
Annu Rev Pathol; 2019 Jan; 14():469-495. PubMed ID: 30355151
[TBL] [Abstract][Full Text] [Related]
65. TDP-43 N-terminal domain dimerisation or spatial separation by RNA binding decreases its propensity to aggregate.
Miura M; Sakaue F; Matsuno H; Morita K; Yoshida A; Hara RI; Nishimura R; Nishida Y; Yokogawa M; Osawa M; Yokota T
FEBS Lett; 2023 Jun; 597(12):1667-1676. PubMed ID: 37177801
[TBL] [Abstract][Full Text] [Related]
66. Abl kinase-mediated FUS Tyr526 phosphorylation alters nucleocytoplasmic FUS localization in FTLD-FUS.
Motaln H; Čerček U; Yamoah A; Tripathi P; Aronica E; Goswami A; Rogelj B
Brain; 2023 Oct; 146(10):4088-4104. PubMed ID: 37071594
[TBL] [Abstract][Full Text] [Related]
67. Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue.
Liu-Yesucevitz L; Bilgutay A; Zhang YJ; Vanderweyde T; Citro A; Mehta T; Zaarur N; McKee A; Bowser R; Sherman M; Petrucelli L; Wolozin B
PLoS One; 2010 Oct; 5(10):e13250. PubMed ID: 20948999
[TBL] [Abstract][Full Text] [Related]
68. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity.
Johnson BS; Snead D; Lee JJ; McCaffery JM; Shorter J; Gitler AD
J Biol Chem; 2009 Jul; 284(30):20329-39. PubMed ID: 19465477
[TBL] [Abstract][Full Text] [Related]
69. p62 overexpression induces TDP-43 cytoplasmic mislocalisation, aggregation and cleavage and neuronal death.
Foster AD; Flynn LL; Cluning C; Cheng F; Davidson JM; Lee A; Polain N; Mejzini R; Farrawell N; Yerbury JJ; Layfield R; Akkari PA; Rea SL
Sci Rep; 2021 Jun; 11(1):11474. PubMed ID: 34075102
[TBL] [Abstract][Full Text] [Related]
70. Praja1 RING-finger E3 ubiquitin ligase suppresses neuronal cytoplasmic TDP-43 aggregate formation.
Watabe K; Kato Y; Sakuma M; Murata M; Niida-Kawaguchi M; Takemura T; Hanagata N; Tada M; Kakita A; Shibata N
Neuropathology; 2020 Dec; 40(6):570-586. PubMed ID: 32686212
[TBL] [Abstract][Full Text] [Related]
71. [TDP-43 proteinopathies: ALS and frontotemporal dementias].
Prudlo J
Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S25-7. PubMed ID: 19685386
[TBL] [Abstract][Full Text] [Related]
72. Transcriptomic Changes Due to Cytoplasmic TDP-43 Expression Reveal Dysregulation of Histone Transcripts and Nuclear Chromatin.
Amlie-Wolf A; Ryvkin P; Tong R; Dragomir I; Suh E; Xu Y; Van Deerlin VM; Gregory BD; Kwong LK; Trojanowski JQ; Lee VM; Wang LS; Lee EB
PLoS One; 2015; 10(10):e0141836. PubMed ID: 26510133
[TBL] [Abstract][Full Text] [Related]
73. Elevated expression of TDP-43 in the forebrain of mice is sufficient to cause neurological and pathological phenotypes mimicking FTLD-U.
Tsai KJ; Yang CH; Fang YH; Cho KH; Chien WL; Wang WT; Wu TW; Lin CP; Fu WM; Shen CK
J Exp Med; 2010 Aug; 207(8):1661-73. PubMed ID: 20660618
[TBL] [Abstract][Full Text] [Related]
74. Impaired nuclear transport induced by juvenile ALS causing P525L mutation in NLS domain of FUS: A molecular mechanistic study.
Basu S; Rajendra KC; Alagar S; Bahadur RP
Biochim Biophys Acta Proteins Proteom; 2022 Apr; 1870(4):140766. PubMed ID: 35134572
[TBL] [Abstract][Full Text] [Related]
75. Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma.
Bentmann E; Haass C; Dormann D
FEBS J; 2013 Sep; 280(18):4348-70. PubMed ID: 23587065
[TBL] [Abstract][Full Text] [Related]
76. TTR (transthyretin) leads the autophagy disaster relief team against TARDBP/TDP-43 proteinopathy.
Chu YP; Ho PC; Tsai KJ
Autophagy; 2023 Aug; 19(8):2403-2405. PubMed ID: 36633448
[TBL] [Abstract][Full Text] [Related]
77. TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Baloh RH
FEBS J; 2011 Oct; 278(19):3539-49. PubMed ID: 21777387
[TBL] [Abstract][Full Text] [Related]
78. Phase to Phase with TDP-43.
Sun Y; Chakrabartty A
Biochemistry; 2017 Feb; 56(6):809-823. PubMed ID: 28112502
[TBL] [Abstract][Full Text] [Related]
79. In vivo analysis of aggregation propensity of low levels of mislocalized TDP-43 on cytopathological and behavioral phenotype of ALS/FTLD.
Wada H; Hikiami R; Kusui M; Minamiyama S; Asada-Utsugi M; Shodai A; Muramatsu SI; Morimura T; Urushitani M
Neurosci Res; 2023 Aug; 193():41-51. PubMed ID: 36804599
[TBL] [Abstract][Full Text] [Related]
80. TDP-43 and FUS en route from the nucleus to the cytoplasm.
Ederle H; Dormann D
FEBS Lett; 2017 Jun; 591(11):1489-1507. PubMed ID: 28380257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
